Dec. 15 at 4:30 PM
Quipt Home Medical announced it has entered into a definitive all-cash agreement to be acquired by a special purpose acquisition vehicle backed by Kingswood Capital Management and Forager Capital Management. The transaction values the company at about
$260 million, including debt, with shareholders to receive
$3.65 per share, representing a 162% premium to the unaffected share price prior to the initial proposal.
Upon completion, Quipt will become a privately held company and will cease U.S. and Canadian public reporting. The deal is not subject to financing conditions, with Kingswood providing a capital commitment to fund the acquisition. Quipt’s board unanimously recommends that shareholders approve the transaction, citing substantial and certain value following a comprehensive review of strategic alternatives.
$QIPT